8-K: Alchemy Investments Acquisition Corp 1 Faces Nasdaq Delisting

Alchemy Investments Acquisition Corp 1 will be delisted from Nasdaq on May 14, 2026, after failing to complete a business combination within the required 36-month timeframe.

Summary

• Alchemy Investments Acquisition Corp 1 received a delisting notice from Nasdaq on April 7, 2026.
• The company failed to meet the requirement under IM-5101-2 to complete an initial business combination within 36 months of its IPO registration statement becoming effective.
• The 36-month deadline expired on May 4, 2026.
• The company has decided not to appeal the Nasdaq determination.
• Trading on Nasdaq will be suspended at the opening of business on May 14, 2026.
• The company expects its securities to transition to the over-the-counter (OTC) market starting May 14, 2026.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development, as the company has failed to execute its primary business objective and is losing its major exchange listing.

Positives

• The company has provided clear transparency regarding the delisting timeline and future trading venue.

Negatives

• Failure to complete a business combination within the mandated 36-month period.
• Forced delisting from the Nasdaq Stock Market.
• Loss of liquidity and prestige associated with a major exchange listing.

Risks

• Transition to the over-the-counter market typically results in lower trading volume and reduced analyst coverage.
• Potential for increased volatility and wider bid-ask spreads on the OTC market.
• Inability to meet the original strategic objective of completing a business combination within the SPAC lifecycle.

Future Outlook

The company intends to move its securities to the over-the-counter market following the suspension of its Nasdaq listing on May 14, 2026.

Management Comments

• The company will not appeal Nasdaq's determination to delist the company's securities.

Industry Context

StockSavvy.ai notes that this event is consistent with the broader trend of SPACs failing to identify and close merger targets within their allotted lifecycles, leading to liquidation or delisting as the SPAC boom of 2020-2021 continues to unwind.

Comparison to Industry Standards

• The failure to complete a business combination within the 36-month window is a common outcome for SPACs that struggle to find suitable acquisition targets in the current high-interest-rate environment.
• The decision not to appeal is standard for SPACs that have exhausted their time limit and lack a viable path to a merger.

Stakeholder Impact

• Shareholders face reduced liquidity and potential price volatility due to the move to the OTC market.
• The company's ability to attract future investment or merger partners may be negatively impacted by the delisting.

Next Steps

• Suspension of trading on Nasdaq on May 14, 2026.
• Commencement of trading on the over-the-counter market on May 14, 2026.
• Filing of Form 25-NSE with the SEC to finalize the removal from Nasdaq.

Key Dates

Recommendation

The failure to complete a business combination and the subsequent delisting from a major exchange signals a failure of the SPAC's investment thesis, typically warranting an exit for investors.

Keywords

SPAC, Delisting, Nasdaq, Alchemy Investments Acquisition Corp 1, Business Combination, OTC